VI Belgium
The computed 12-month bankruptcy probability of VI Belgium is 0.8% (low). The 2025 annual accounts show equity of €2.79M and a net result of €89k. Its solvency ranks better than 60% of 338 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €2.79M |
| Net result | €89k |
| Staff (FTE) | 7.2 |
| Better than sector | 60% |
Strong profile, led by solvency.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 46.2% | 36.5% | |
| Net result | €89k | €44k | |
| Equity | €2.79M | €279k | |
| Gross operating margin | €1.17M | €244k | |
| Staff costs | €782k | €174k |
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €159k |
| Net profit | €89k |
| Cash flow | €89k |
| Staff costs | €782k |
| Income taxes | €59k |
| Dividends | - |
| Total assets | €6.04M |
| Equity | €2.79M |
| Debt | €3.25M |
| of which ≤ 1y | €3.13M |
| of which > 1y | - |
| Working capital | €2.90M |
| Employees (FTE) | 7.2 |
| 2025 | |
|---|---|
| Current ratio | 1.93 |
| Quick ratio | 1.01 |
| Working capital ratio | 48.0% |
| Solvency | 46.2% |
| Debt / equity | 1.16 |
| Long-term debt ratio | - |
| Interest coverage | 16.06 |
| Gross margin | - |
| Net margin | - |
| ROA | 1.5% |
| ROE | 3.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €6.04M |
| Fixed assets | 21/28 | €6k |
| Tangible fixed assets | 22/27 | €6k |
| Current assets | 29/58 | €6.03M |
| Stocks & contracts in progress | 3 | €2.86M |
| Amounts receivable within one year | 40/41 | €2.54M |
| Cash & bank | 54/58 | €611k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €6.04M |
| Equity | 10/15 | €2.79M |
| Contributions / capital | 10/11 | €166k |
| Accumulated profits (losses) | 14 | €2.62M |
| Amounts payable | 17/49 | €3.25M |
| Amounts payable within one year | 42/48 | €3.13M |
| Trade debts payable within one year | 44 | €2.70M |
| Income statement | ||
| Gross operating margin | 9900 | €1.17M |
| Operating result | 9901 | €158k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €10k |
| Result before taxes | 9903 | €148k |
| Income taxes | 67/77 | €59k |
| Net result for the period | 9904 | €89k |
| Result to be appropriated | 9905 | €89k |
-
Current01-07-2025 → present
-
Current01-07-2025 → present
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BV PwC BedrijfsrevisorenCurrent Statutory auditor · represented by Khadija Aourz |
- | 07-01-2026 → present |
Show 1 earlier auditors
| DELOITTE Bedrijfsrevisoren BV Statutory auditor · represented by Pieter-Jan Van Durne |
- | - → 07-01-2026 |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 12-12-2024 |
| Status | Active |
| Postal code | 1800 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23645C0156/00D002 | Flanders | 2.0 ha | 1 · 1,717 m² | 20.5 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 8 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
07-05-2026 Khadija Aourz appointed as statutory auditor
- Khadija Aourz, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Khadija Aourz",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Ter verduidelijking bevestigt de enige aandeelhouder hierbij de benoeming van PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar voor de boekjaren afgesloten op 31 december 2026, 2027 en 2028. Deze vennootschap wijst ov"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1017.267.704",
"name_full": "VI BELGIUM",
"legal_form": "BV"
}
}14-04-2026 Act object · Merger · Accounting effect · Approval
- Act object: DIVERSEN · VI Belgium BV
- Filing: 2026-04-10 · VI Belgium BV
- Publication: 2026-04-14 · VI Belgium BV
- Merger: type: fusion_by_takeover, description: vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical · VI Belgium BV
- Accounting effect: 2026-01-01 · VI Belgium BV
- Approval: body: buitengewone algemene vergaderingen, description: ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen · VI Belgium BV
- Notarial deed: 2026-04-01 · VI Belgium BV
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : DIVERSEN",
"value": "DIVERSEN",
"object": null,
"subject": "e1"
},
{
"type": "filing",
"quote": "Neergelegd 10-04-2026",
"value": "2026-04-10",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 14/04/2026",
"value": "2026-04-14",
"object": null,
"subject": "e1"
},
{
"type": "merger",
"quote": "Het doel van de voorgestelde fusie is derhalve een vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical.",
"value": {
"type": "fusion_by_takeover",
"description": "vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical"
},
"object": "e2",
"subject": "e1"
},
{
"type": "accounting_effect",
"quote": "De datum vanaf wanneer de handelingen van VI Belgium voor boekhoudkundige doeleinden geacht worden te zijn verricht namens de overnemende vennootschap is vastgesteld op 1 januari 2026.",
"value": "2026-01-01",
"object": "e2",
"subject": "e1"
},
{
"type": "approval",
"quote": "verklaren dat zij dit fusievoorstel ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen.",
"value": {
"body": "buitengewone algemene vergaderingen",
"description": "ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen"
},
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Opgesteld op 1 april 2026, in vier originele exemplaren",
"value": "2026-04-01",
"object": "e3",
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 13286,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "1017.267.704",
"kind": "company",
"name": "VI Belgium BV",
"attrs": {
"vat": "BE 1017.267.704",
"role": "Over te nemen vennootschap",
"seat": "Medialaan 36, 1800 Vilvoorde",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": "0401.993.536",
"kind": "company",
"name": "Teleflex Medical BV",
"attrs": {
"vat": "BE 0401.993.536",
"role": "Overnemende vennootschap",
"seat": "Marnixlaan 23, 1000 Brussel",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Yorik DESMYTTERE",
"attrs": {
"role": "Notaris"
}
}
]
}14-04-2026 Act object · Merger · Accounting effect · Notarial deed
- Act object: BENAMING, DIVERSEN · TELEFLEX MEDICAL BV
- Filing: 2026-04-10 · TELEFLEX MEDICAL BV
- Publication: 2026-04-14 · TELEFLEX MEDICAL BV
- Merger: type: fusion_by_takeover, description: vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical · VI BELGIUM BV
- Accounting effect: 2026-01-01 · VI BELGIUM BV
- Notarial deed: 2026-04-01 · Yorik DESMYTTERE
- Approval: body: buitengewone algemene vergaderingen, description: ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen · TELEFLEX MEDICAL BV
- Approval: body: buitengewone algemene vergaderingen, description: ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen · VI BELGIUM BV
- Share transfer: description: alle aandelen van VI Belgium in het bezit zijn van Teleflex Medical · TELEFLEX MEDICAL BV
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : BENAMING, DIVERSEN",
"value": "BENAMING, DIVERSEN",
"object": null,
"subject": "e1"
},
{
"type": "filing",
"quote": "Neergelegd 10-04-2026",
"value": "2026-04-10",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 14/04/2026",
"value": "2026-04-14",
"object": null,
"subject": "e1"
},
{
"type": "merger",
"quote": "Het doel van de voorgestelde fusie is derhalve een vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical.",
"value": {
"type": "fusion_by_takeover",
"description": "vereenvoudigde fusie door overname van VI Belgium door Teleflex Medical"
},
"object": "e1",
"subject": "e2"
},
{
"type": "accounting_effect",
"quote": "De datum vanaf wanneer de handelingen van VI Belgium voor boekhoudkundige doeleinden geacht worden te zijn verricht namens de overnemende vennootschap is vastgesteld op 1 januari 2026.",
"value": "2026-01-01",
"object": "e1",
"subject": "e2"
},
{
"type": "notarial_deed",
"quote": "Opgesteld op 1 april 2026, in vier originele exemplaren",
"value": "2026-04-01",
"object": null,
"subject": "e3"
},
{
"type": "approval",
"quote": "verklaren dat zij dit fusievoorstel ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen.",
"value": {
"body": "buitengewone algemene vergaderingen",
"description": "ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen"
},
"object": null,
"subject": "e1"
},
{
"type": "approval",
"quote": "verklaren dat zij dit fusievoorstel ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen.",
"value": {
"body": "buitengewone algemene vergaderingen",
"description": "ter goedkeuring zullen voorleggen aan hun respectieve buitengewone algemene vergaderingen"
},
"object": null,
"subject": "e2"
},
{
"type": "share_transfer",
"quote": "De raad van bestuur van VI Belgium en de raad van bestuur van Teleflex Medical erkennen dat op het moment van de fusie alle aandelen van VI Belgium in het bezit zijn van Teleflex Medical.",
"value": {
"description": "alle aandelen van VI Belgium in het bezit zijn van Teleflex Medical"
},
"object": "e2",
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 13299,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0401.993.536",
"kind": "company",
"name": "TELEFLEX MEDICAL BV",
"attrs": {
"vat": "BE 0401.993.536",
"seat": "Marnixlaan 23, 1000 Brussel",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": "1017.267.704",
"kind": "company",
"name": "VI BELGIUM BV",
"attrs": {
"vat": "BE 1017.267.704",
"seat": "Medialaan 36, 1800 Vilvoorde",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Yorik DESMYTTERE",
"attrs": {
"role": "Notaris"
}
}
]
}03-02-2026 1 director appointed, 1 resigning
- Khadija Aourz, Commissaris
- Pieter-Jan Van Durne, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Pieter-Jan Van Durne",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-01-07",
"evidence_quote": "De enige aandeelhouder beslist overeenkomstig artikel 3:66 \u00A71 van het Wetboek van vennootschappen en verenigingen tot het voortijdig ontslag van de commissaris van de Vennootschap, zijnde Deloitte Bedrijfsrevisoren BV, met zetel te Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, vast vertegenwoordi",
"discharge_granted": true
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Khadija Aourz",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2026-01-07",
"evidence_quote": "De enige aandeelhouder benoemt PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar. Deze vennootschap wijst overeenkomstig artikel 3:60 van het Wetboek van vennootschappen en verenigingen Khadija Aourz BV aan voor de uit",
"discharge_granted": false
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1017.267.704",
"name_full": "VI BELGIUM",
"legal_form": "BV"
}
}22-07-2025 2 directors appointed
- Jan Breugelmans, Bestuurder
- Matthew James, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jan Breugelmans",
"address": null,
"birth_date": null
},
"effective_date": "2025-07-01",
"evidence_quote": "De enige aandeelhouder beslist om de volgende personen te benoemen als nieuwe bestuurder van de Vennootschap met ingang vanaf 1 juli 2025: - Jan Breugelmans, woonplaats kiezend op de zetel van de Vennootschap;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Matthew James",
"address": null,
"birth_date": null
},
"effective_date": "2025-07-01",
"evidence_quote": "De enige aandeelhouder beslist om de volgende personen te benoemen als nieuwe bestuurder van de Vennootschap met ingang vanaf 1 juli 2025: - Matthew James, woonplaats kiezend op de zetel van de Vennootschap."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1017.267.704",
"name_full": "VI BELGIUM",
"legal_form": "BV"
}
}24-06-2025 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1017.267.704",
"name_full": "VI BELGIUM",
"legal_form": "BV"
}
}16-12-2024 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "1800 Vilvoorde, Medialaan 36",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0882.946.854",
"name": "Biotronik International Vertriebs GmbH"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": "0882.946.854",
"holder_org_name": "Biotronik International Vertriebs GmbH",
"contribution_type": "cash",
"amount_paid_in_eur": 100000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 10000,
"amount_subscribed_eur": 100000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 100000,
"subject_company": {
"kbo": "1017.267.704",
"name_full": "VI Belgium",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2024-12-03",
"post_incorporation_mandates": []
}| Legal nameNL | VI Belgium |